Mini-Review
Abstract
Full TextPDF Background: Many cases of newly diagnosed diabetes were reported in association with coronavirus 2019 (COVID-19) caused by the severe acute respiratory syndrome-associated coronavirus-2 (SARS-CoV-2).
Objective: To clarify whether COVID-19 triggers new diabetes or unmask pre-existing undiagnosed diabetes.
Methods: PubMed search of literature up to February 3, 2021. Search terms included diabetes, COVID-19, diagnosis, hemoglobin A1c (HbA1c), diabetic ketoacidosis, diabetes ketoacidosis, pancreatitis. Case reports, case series, retrospective studies, reviews, and pertinent in-vitro investigations were reviewed.
Results: Retrospective studies and case series suggest that COVID-19 can worsen diabetes control and precipitate hyperglycemic crises in patients admitted to the hospital. Majority of these patients had pre-existing undiagnosed type 2 diabetes as reflected by elevated HbA1c levels on admission. Many patients presenting with hyperglycemia and normal HbA1c levels may have transient stress hyperglycemia. This group of patients are misclassified as new-onset diabetes despite lack of patient follow-up after discharge. Only one case report of possible new-onset diabetes described a patient with pre-diabetes who progressed to severe diabetes 6 weeks following COVID-19 pneumonia. Mechanisms of worsening glycemic control by COVID-19 infection include increased release of cytokines and insulin counter-regulatory hormones. Binding of SARS-CoV-2 to pancreatic β-cells and their subsequent destruction by the virus as another mechanism requires further studies.
Conclusion: COVID-19 infection commonly unmasks pre-existing diabetes. Follow-up of patients presenting with new-onset hyperglycemia after hospital discharge is essential to distinguish between stress hyperglycemia and new-onset diabetes.
Research Article
Abstract
Full TextPDF
Supplementary File Diabetes is a group of diseases characterized by high levels of blood sugar for an extended period. Despite newer and effective therapy, current treatment is riddled with fundamental challenges. To overcome the adverse effects of existing drugs, regenerative medicine has emerged as an essential treatment, for which tissue engineering may serve as a foundation for the repair of pancreatic cells secreting insulin. Different polymeric scaffolds have been explored for pancreatic tissue engineering. In the current study, a continuation of our preceding work we attempt to test the role of previously synthesized agarose-chitosan coated silver nanocomposite scaffold (AG-CHNp) for the long-term growth of pancreatic cells. Pancreatic cells were isolated from BALB/c mice and were characterized by dithizone (DTZ) staining, real time polymerase chain reaction (RT-PCR), western blotting, and flow cytometry for characteristic pancreatic markers. The isolated population of cells was grown on scaffolds and its effectiveness towards insulin secretion was studied. The isolated population was found to be positive for glucagon, PDX-1 and Pax-4, while a 200-fold change transcript level of insulin was observed. The cells upon seeding on the scaffolds exhibited sustained growth and insulin secretion as confirmed by western blotting. Overall, the study demonstrates the suitability and application of AG-CHNp for pancreatic tissue engineering.
Research Article
Abstract
Full TextPDF Background: This study aimed to determine long-term effect of intensive insulin therapy on prevention, progression, and development of chronic diabetes complications, both micro and macrovascular events. This study also aimed to evaluate long-term sustainability of glycemic control of patients on intensive insulin treatment.
Methods: A retrospective review of adult type 2 diabetes mellitus (T2DM) patients on intensive insulin therapy for ≥7 years. Demographic data, co-morbidities, body mass index (BMI), hemoglobin A1c (HbA1c), hospitalization were collated. Majority received intensive insulin therapy with combination of premixed 70/30 given two times a day and fast short acting analogue given premeal three times a day, with the addition of glargine or degludec once a day in some.
Results: Among 76 patients, 62% were males and 38% were females. Mean age at diagnosis and last visit were 53 and 65 years, respectively. At time of diagnosis, patient had the following co-morbidities: hypertension (32%), dyslipidemia (13%), non-dialyzable chronic kidney disease (CKD) (4%), thyroid disease (1%), pulmonary tuberculosis (1%). In terms of long-term complications, event rates during follow up period are as follows: 0.001 per person-year for acute coronary event; 0.002 per person-year for CKD needing dialysis, 0.009 per person-year for cerebrovascular accident. There were no blindness and amputation observed. There is a statistical difference between HbA1c levels at time of diagnosis (8.53 ± 1.86) and last follow up (7.83 ± 1.71) (P = 0.00). After a median follow up of 12 years (7–22 years), glycemic control was sustained with an HbA1c of ≤7% and ≤8% in 32% and 45% of patients, respectively.
Conclusion: With intensive insulin therapy, micro and macrovascular complications can be prevented significantly. Long-term sustainability of glycemic control was also achieved.
Review Article
Abstract
Full TextPDF The physiologic process of micturition plays an essential role in the ability of the human body
to regulate homeostasis. When the urinary system encounters an obstruction such as a foreign
body within the bladder or other prostatic diseases like benign prostatic hyperplasia (BPH),
alternative measures to drain the bladder is required, this birthed the use of urethral catheters
& the catheterization procedure. Urethral catheterization dates to the early days of medicine
and while it is mostly a routine procedure in this era, the total understanding of its indications,
proper techniques, and associated complications remains an essential tool in the arsenal of a
practicing physician.
Review Article
Abstract
Full TextPDF The author describes one of his hypothetical theories on the relationship between life longevity and overall metabolism, the macrosystem view, specifically the stress and daily life routine regularity, two micro-categories. He has spent ~25,000 h over 7.5 years (2010–2019) to conduct research on metabolism, endocrinology, and chronic diseases, specifically diabetes. These big data analytics is based on ~600,000 data over 2.5 years. His developed metabolism model has shed some light about the impact on his life longevity due to his overall metabolic changes, especially his stress level and life routine regularity. Having a strong lifestyle management leads into a good metabolic state, which then converts into a strong immunity to fight against three major disease categories, chronic diseases and complications (50% of death), cancers (29% of death), and infectious diseases (11% of death), with the remaining 10% of non-diseases related to death cases. This is a logical way to achieve longevity which is the core of geriatrics.
Systematic Review
Abstract
Full TextPDF The world has been facing a novel coronavirus, COVID-19 pandemic since the beginning of 2020. Until the end of May, 5.9 million confirmed cases and 350.000 deaths have been reported. Diabetes, as a prevalent chronic disease is known to be a risk factor for infection onset and disease severity. In this study, a systematic review has been planned to determine the relation between COVID-19 and diabetes among other comorbidities. For this aim, 564 researches have been determined about the topic and 48 of them have been evaluated in the review. The researches have been done with 91.172 COVID-19 patients, and diabetes ratio among the researches differ from 3.3% to 40%. Besides, age, hypertension, cardiovascular diseases, smoking status, and respiratory diseases have been evaluated in the review as common comorbidities. As a result of the study, diabetes and hypertension have been determined to be important risk factors in COVID-19 onset and severity. However, further detailed multidisciplinary researches about COVID-19, diabetes and comorbidities will be valuable in the COVID-19 pandemic process and future aspects.
Review Article
Abstract
Full TextPDF Haptoglobin (HAP) is genetically polymorphic with three primary genotypes, HAP 1-1, 2-1 and 2-2. Each genotype differs phenotypically in HAP structure and ability to perform its main function, scavenging free hemoglobin (Hb) released from old red blood cells. Patients with both diabetes and the genotype 2-2 appear to be at an increased cardiovascular risk than those with the other genotypes or patients without diabetes. This risk appears elevated with worse glycemic control. The exact mechanism for this increased risk is unknown but there are several proposed causes. Vitamin E has shown to reduce cardiovascular events in patients with both diabetes and the 2-2 genotype but the safety of implementing such therapy remains unknown. Recent post-hoc evaluation of a landmark study originally designed to assess the benefits and risks of more aggressive glycemic control suggests there may be a cardiovascular benefit in patients with diabetes and the 2-2 genotype that is not seen in those with the other genotypes. This information, if confirmed with post-hoc evaluation of other similar landmark studies as well as evaluation of genotype differences in recent cardiovascular safety studies with glucagon-like peptide agonists or sodium-glucose cotransporter inhibitors, could provide clinicians with an avenue to better identify patients most at risk for cardiovascular events and who may benefit the most from more aggressive glycemic control or use of other antihyperglycemic agents.
Research Article
Abstract
Full TextPDF Introduction: Approximate Entropy (ApEn) is a widely enforced metric to evaluate the chaotic response and irregularities of RR intervals from an electrocardiogram. We applied the metric to estimate these responses in subjects with type 1 diabetes mellitus (DM1). So far, as a technique it has one key problem - the accurate choices of the tolerance (r) and embedding dimension (M). So, we attempted to overcome this drawback by applying different groupings to detect the optimum.
Methods: We studied 46 subjects split into two equal groups: DM1 and control. To evaluate autonomic modulation the heart rate was measured for 30 min in a supine position without any physical, sensory, or pharmacological stimuli. For the time-series, the ApEn was applied with set values for r (0.1→0.5 in intervals of 0.1) and M (1→5 in intervals of 1) and the differences between the two groups and their effect size by two measures (Cohen’s ds and Hedges’s gs) were computed.
Results: The highest value of statistical significance accomplished for the effect sizes (ES) for any of the combinations performed was -0.7137 for Cohen’s ds and -0.7015 for Hedges’s gs with M = 2 and r = 0.08.
Conclusion: ApEn was able to identify the reduction in chaotic response in DM1 subjects. Still, ApEn is relatively unreliable as a mathematical marker to determine this.
Original Research
Abstract
Full TextPDF This paper focuses on the author’s invented robotic software technology, the artificial intelligence glucometer (AIG) product, to provide a diagnosis for diabetes disease and glucose control. From 2010–2013, he self-studied internal medicine and food nutrition. In 2014, he further utilized topology concept, partial differential equation, non-linear algebra, and finite element engineering concept to develop a human metabolism’s mathematical model. It consists of 10 categories and ~500 elements with ~1.5 million collected data of his own body health, disease conditions, and lifestyle details. Starting from 2015, he focused on the root cause of diabetes, which is “glucose”. By applying wave theory, signal processing, energy theory, optical physics, structural & fluid dynamics from physics and engineering modeling; pattern and segmentation analysis, time/space/frequency domain analyses, big data analytics, machine learning and self-correction, prediction equations from mathematics and computer science, he decided to utilize his robotic software as the foundation to further build up his needed medical research and clinical tools. By using the artificial intelligence (AI) robotic software, the author’s average glucose decreased from 280 mg/dL to 118 mg/dL and his hemoglobin A1C (HbA1C or A1C) reduced from 10%+ to below 6.5%, without diabetes medications. All his diabetes complications are either under control or have subsided. This innovative technology of his robotic software for glucose prediction and diabetes control has also been proven by many other patients, who have achieved equally remarkable medical results.
Research Article
Abstract
Full TextPDF The present analysis was to identify the socioeconomic factors responsible for prevalence of obesity and diabetes simultaneously among adults of 18 years and above residing in both urban and rural localities of Bangladesh. Accordingly, information was collected from 960 adults by some doctors and nurses from and nearby their working places. Among the investigated adults, 66.9% were diabetic patients and 20.2% of them were obese. In the sample, total obese adults were 29.3%. Obesity and diabetes were significantly associated. Prevalence of obesity and diabetes were significantly associated with age, marital status and utilization of time. Income was the most responsible factor for this simultaneous health hazard followed by expenditure, physical activity, marital status, religion and occupation. This conclusion was drawn from the results of odds ratio and discriminant analysis.